Clinical Trial

Histamine as a Molecular Transducer of Adaptation to Exercise

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study is investigating the role of histamine in generating adaptation to exercise
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-01-11; most recent amendment 2026-01-21.
Status change: Recruiting → Active, Not Recruiting 2026-01-21
Trial Details
NCT Number NCT05206227
Lead Sponsor University of Oregon
Conditions Postexercise Hypotension
Enrollment 80 participants
Start Date 2021-07-28
Primary Completion 2025-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-23